Home › Funds › Tejara Capital Ltd › HRTX

Tejara Capital Ltd position in HRTX

HERON THERAPEUTICS INC · Health Care

Tejara Capital Ltd reported holding 6,492,878 shares of HRTX (HERON THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 1.00% of its reported portfolio and ranking #26 among its reported holdings. Tejara Capital Ltd has disclosed HRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)6.49M sh
Reported value held$2.04M
Portfolio Weight1.00%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Tejara Capital Ltd's HRTX position evolved

Tejara Capital Ltd first disclosed a stake in HRTX in Q3 2023 at 2,109,681 shares (US$2.2M). The position peaked in Q2 2024 at 4,187,860 shares, worth US$14.7M. Across 13 filings, Tejara Capital Ltd increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 6,492,878 shares valued at US$2.0M. Notable position changes include a 150% increase in Q4 2023 (shares rose 63% over the following quarter), a 27% increase in Q3 2024 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.11M $2.17M New
Q4 2023 5.28M $8.97M Add
Q1 2024 4.41M $12.22M Reduce
Q2 2024 4.19M $14.66M Reduce
Q3 2024 5.31M $10.56M Add
Q4 2024 4.66M $7.13M Reduce
Q1 2025 4.58M $10.07M Reduce
Q2 2025 4.52M $9.35M Reduce
Q3 2025 4.59M $5.78M Add
Q4 2025 5.13M $6.67M Add
Q1 2026 6.34M $5.07M Add
Q2 2026 6.51M $2.78M Add
Q3 2026 6.49M $2.04M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HRTX and 13F data

HRTX (HERON THERAPEUTICS INC) is a Health Care company. 7 other funds we track also report a position in HRTX — the largest reported positions include Velan Capital Investment Management LP (US$3.7M), TANG CAPITAL MANAGEMENT LLC (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HRTX

All HRTX fund holders →

FAQ

How long has Tejara Capital Ltd held HRTX?

Tejara Capital Ltd has disclosed HRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Tejara Capital Ltd's current position in HRTX?

As of Q3 2026, Tejara Capital Ltd holds 6.49M shares of HRTX (HERON THERAPEUTICS INC), valued at $2.04M, representing 1.00% of its reported portfolio and ranking #26.

Has Tejara Capital Ltd been buying or selling HRTX?

In the latest 13F filing (Q3 2026), Tejara Capital Ltd held unchanged its position in HRTX. The position peaked in Q2 2024 at 4.19M shares.

Which other funds hold HRTX?

Other major institutional holders of HRTX include Velan Capital Investment Management LP, TANG CAPITAL MANAGEMENT LLC, among 7 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.